An analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results